skip to primary navigationskip to content

18.10.16 Emma Rawlins' group shows that extrinsic signals drive lung epithelial cell fate

last modified Oct 25, 2016 10:31 AM
In this Development paper, the Rawlins group with colleagues in Edinburgh investigate the mechanisms controlling the fate of developing lung epithelial cells
18.10.16 Emma Rawlins' group shows that extrinsic signals drive lung epithelial cell fate

Excerpt from Fig. 2: Sections of mouse lungs with labelled progenitor grafts.

Lung epithelial tip progenitors integrate glucocorticoid- and STAT3-mediated signals to control progeny fate

Usua Laresgoiti, Marko Z. Nikolić, Chandrika Rao, Jane L. Brady, Rachel V. Richardson, Emma J. Batchen, Karen E. Chapman & Emma L. Rawlins, Development (2016) 143: 3686-3699; doi: 10.1242/dev.134023


The epithelial cells found at the distal tips of the developing lung comprise a multipotent progenitor population. During development, these cells first give rise to bronchiolar cells, which form the conducting airways, but then switch to producing alveolar cells, which form the sites of gas exchange.

In this paper, Emma Rawlins and co-workers investigate the factors that control this transition in the mouse lung. They report that distal tip progenitors begin to express alveolar fate markers at around E16.5. Using a grafting assay, the researchers reveal that extrinsic, rather than intrinsic, factors determine the fate of tip progenitors. Importantly, they reveal that the glucocorticoid and STAT3 signalling pathways operate in parallel to promote alveolar fate; both pathways are sufficient but not necessary for specifying alveolar cells. Finally, the authors demonstrate that STAT3 signalling is also active at a similar stage of lung development in humans.

Overall, these results highlight that the fate of lung epithelial cells is controlled by extrinsic signalling from surrounding tissues, a finding that has important implications for developing therapies that can restore alveolar capacity in human lungs.



Text above derived from feature article in Development, under Creative Commons (CC BY 4.0).


Read more about research in the Rawlins lab.

Watch Emma Rawlins describe her research on video.

Studying development to understand disease

The Gurdon Institute is funded by Wellcome and Cancer Research UK to study the biology of development, and how normal growth and maintenance go wrong in cancer and other diseases.

combinedLogo x3 trans2018


Share this

Integrin signaling downregulates filopodia in muscle-tendon attachment

Defining Lineage Potential and Fate Behavior of Precursors during Pancreas Development

DDX3X RNA helicase affects breast cancer cell cycle progression by regulating expression of KLF4

Natural Genetic Variation in a Multigenerational Phenotype in C. elegans

On the origin of the human germline

Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells 

Genome-Scale Oscillations in DNA Methylation during Exit from Pluripotency

Immune Cell Dynamics Unfolded by Single-Cell Technologies

Chromatin Accessibility Impacts Transcriptional Reprogramming in Oocytes

Integrin α2 marks a niche of trophoblast progenitor cells in first trimester human placenta

Inhibition of the acetyltransferase NAT10 normalizes progeric and aging cells by rebalancing the Transportin-1 nuclear import pathway

SLAM-ITseq: Sequencing cell type-specific transcriptomes without cell sorting

SRSF3 maintains transcriptome integrity in oocytes by regulation of alternative splicing and transposable elements

scmap: projection of single-cell RNA-seq data across data sets

Single-cell transcriptomics reveals a new dynamical function of transcription factors during embryonic hematopoiesis

Map of synthetic rescue interactions for the Fanconi anemia DNA repair pathway identifies USP48

The developmental origin of brain tumours: a cellular and molecular framework



Link to full list on PubMed